2022
DOI: 10.1111/jan.15163
|View full text |Cite
|
Sign up to set email alerts
|

Mixed diabetic retinopathy screening coverage results in Indigenous Australian primary care settings: A nurse‐led model of integrated diabetes care

Abstract: Aims To determine eye screening coverage and adherence to national eye screening recommendations of a nurse‐led retinal image‐based model of diabetes education and eye screening in Indigenous primary care clinics. Design A pre‐post study. Methods During January 2018–March 2020 Indigenous Australians with diabetes at three regional Australian clinics were offered eye screening by a nurse‐diabetes educator/retinal imager. At the main site the nurse recruited/scheduled participants, and at satellite sites local c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 43 publications
0
2
0
Order By: Relevance
“…Whether trained neonatal nurses can safely read and interpret the wide-field images, as is currently performed in nurse-led diabetic retinopathy screening, 5,6 has not been fully evaluated. An accurate interpretation would significantly improve communication with families and potentially increase the efficiency of the screening process.…”
Section: What This Study Addsmentioning
confidence: 99%
“…Whether trained neonatal nurses can safely read and interpret the wide-field images, as is currently performed in nurse-led diabetic retinopathy screening, 5,6 has not been fully evaluated. An accurate interpretation would significantly improve communication with families and potentially increase the efficiency of the screening process.…”
Section: What This Study Addsmentioning
confidence: 99%
“…According to the latest American Diabetes Association guidelines, glucose targets are a fas ting plasma glucose level of < 95 mg/dL (5.3 mmol/L) and a 1-hour postprandial glucose level of < 140 mg/dL (7.8 mmol/L) or a 2-hour postprandial glucose level < 120 mg/dL (6.7 mmol/L). In general, the haemoglobin A 1 C target during pregnancy is < 6 % (42 mmol/l) if this can be achieved without significant hypoglycaemia, but the target can be lowered to < 7 % (53 mmol/l) if necessary to prevent hypoglycaemia, because according to N. Mohan and A. Banerjee [20], pregnant women are more prone to metabolic risks, so they should be informed about the symptoms of hypo-and hyperglycaemia. Insulin is the preferred treatment for diabetes type 1 and type 2 during pregnancy, so the woman should be trained in injection techniques, although oral metformin is a possible alternative with its own advantages and disadvantages.…”
Section: оригінальні дослідження / Original Researchesmentioning
confidence: 99%